Authors
John Clark, PharmD, MS, BCPS, FASHP; University of Michigan Health and University of Michigan
College of Pharmacy, Ann Arbor, MI
Toni Fera, BS Pharm, PharmD; Independent Healthcare Consultant, Pittsburgh, PA
Christopher Fortier, PharmD, FASHP; Massachusetts General Hospital, Boston, MA
Kristine Gullickson, PharmD, MBA, FASHP, FMSHP; Allina Health Abbott Northwestern Hospital,
Minneapolis, MN
Amanda Hays, PharmD, MHA, BCPS, CPHQ, DPLA, FASHP; Becton, Dickinson and Company, San
Diego, CA
Lee Murdaugh, BS Pharm, PhD; Cardinal Health, Dublin, OH
Ricky Ogden, Jr., PharmD, MBA, BCPS, FACHE; Children’s Mercy Kansas City, Kansas City, MO
Brian O’Neal, PharmD, MS, FASHP; Children’s Mercy Kansas City, Kansas City, MO
Jordan Rush, PharmD, MS; UNC Health, Chapel Hill, NC
Tyler Vest, PharmD, MS, BCPS, BCSCP; Duke University Hospital, Durham, NC
Read Document Here: https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/preventing-diversion-of-controlled-substances.ashx